Article: Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?

€3.03

SKU: product-article-10961 Category: General

Description
Reviews (0)

Description

Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?

Reviews

There are no reviews yet.

Be the first to review “Article: Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?”

You must be logged in to post a review.

Top

Article: Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?

Description

Reviews

Related products

Article: Highlights in gynaecological cancers

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in breast cancer